Market Overview - The Federal Reserve's mixed non-farm data has led to rising expectations for interest rate cuts, resulting in a volatile sentiment in the Hong Kong stock market, which opened lower but ended positively with the Hang Seng Index rising by 0.92% to 25,468.78 points and a total turnover of HKD 183.14 billion [1] - The forward P/E ratio of the Hang Seng Index is currently at 12.7 times, down 5% from its year-to-date peak, indicating a potential short-term consolidation phase in the market [1] Blue-Chip Stocks Performance - Li Ning (02331) saw a notable increase of 4.26%, closing at HKD 19.07 with a turnover of HKD 613 million, contributing 2.91 points to the Hang Seng Index [2] - China Life (02628) rose by 4.31% to HKD 28.56, contributing 14.03 points, while Pop Mart (09992) increased by 3.44% to HKD 195.7, contributing 7.71 points [2] Sector Highlights - The aviation sector continued its upward trend, with China Southern Airlines (01055) up 5.89% to HKD 5.57, China Eastern Airlines (00753) up 4.02% to HKD 6.73, and Air China (00670) up 3.77% to HKD 4.95 [3][4] - The lithium sector saw strong performance from Tianqi Lithium (09696), which rose by 5.83% to HKD 49.34, and Ganfeng Lithium (01772), which increased by 5.75% to HKD 51.9 [4] Mining Rights Cancellation - The Yichun Natural Resources Bureau announced plans to cancel 27 mining rights, which may impact the lithium supply chain, as the original rights holders will be responsible for ecological restoration [5] - Market analysts suggest that lithium carbonate prices are likely to remain high due to ongoing supply-demand imbalances, with a focus on production capacity and funding movements [6] Brokerage Sector Activity - Chinese brokerage stocks saw a late-session rally, with CITIC Securities (06030) up 3.4% to HKD 27.98, and other major brokerages also posting gains [6] - The recent announcements of dividend distributions by several listed brokerages have contributed to a high level of market activity, with total dividends exceeding HKD 54.8 billion this year [7] Notable Stock Movements - Zhaoyan New Drug (06127) surged by 10.36% to HKD 25.58, driven by increased demand for preclinical testing assets [8] - Drug developer Yaojie Ankang-B (02617) rose by 17.41% to HKD 171.3, following positive clinical trial results for its core product [9] - Yidu International (00259) experienced a decline of 8.44% to HKD 4.12 amid market fluctuations [10]
港股收盘(12.17) | 恒指收涨0.92% “锂业双雄”异动走强 中资券商股尾盘拉升
智通财经网·2025-12-17 08:59